A two-year-old lawsuit begun by Allergan, the makers of BOTOX® Cosmetic, has just been given a favorable ruling in US federal court in California, which issued a permanent injunction against Merz Pharmaceuticals and Merz Aesthetics, which are the two American subsidiaries of German pharmaceutical company, Merz Pharma, makers of the BOTOX® competitor, Xeomin. The court…
